|
MechanismBacterial DNA gyrase inhibitors [+2] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismCell wall inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Clinical Microbiology Institute
0 Patents (Medical) associated with Clinical Microbiology Institute
100 Deals associated with Clinical Microbiology Institute
100 Translational Medicine associated with Clinical Microbiology Institute